Sanofi signs diabetes research agreement with Brigham and Women’s
Chris Reidy
Sanofi SA, the French drug giant that bought Cambridge-based Genzyme Corp. for $20.1 billion last year, announced a research collaboration with Brigham and Women’s Hospital.
